NattoPharma ASA has obtained a renewed Self Affirmed GRAS for their product MenaQ7® in the USA with designated specifications and for associated food uses, as long as production occurs in accordance with Good Manufacturing Practices. Accordingly, NattoPharma can sell MenaQ7® to the food industry in the US since the product, MenaQ7® comply with FDA requirements.
Mr. Peter Carlsson, CEO, states that “this is good news for NattoPharma, hence we can now ramp up the sales effort towards the US food industry, and expect to reposition MenaQ7® as a high quality and reliable vitamin K2 for enrichment of food products. “We are very pleased to have the Self Affirmed GRAS approval in place for our product MenaQ7® in the US” says Carlsson. “This opens immediate potentials in the dairy industry, as well as the non-dairy dairy segment”.
MenaQ7 provides natural vitamin K2 as a fermentation extract whereby vitamin K2 is manufactured using bascillus subtilis natto. This process has the capacity of producing the highly pure and bio-available form of vitamin K2, menaquinone-7 (MK-7). MenaQ7® is the best documented, commercially available natural vitamin K2 with guaranteed actives and stability, clinical substantiation and international patents granted and pending.
For more information on the health benefits of MenaQ7®, please visit www.menaq7.com.
About NattoPharma ASA
NattoPharma, Norway is the exclusive international supplier of MenaQ7®, the natural Vitamin K2. NattoPharma has entered into a multi-year research and development program to substantiate and discover the health benefits of natural vitamin K2 for applications in the exciting marketplace for functional food and health food supplements.
For more information, please visit www.nattopharma.com.